Technical analysis of HCW Biologics Inc. (HCWB): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases.
Price Performance
| 1 month | -5.63% |
| 3 months | -69.27% |
| Year-to-date | -65.46% |
| 1 year | -92.23% |
| 3 years | -99.61% |
| 5 years | -99.77% |
52-Week Range
| 52-week High | $29.34 |
| 52-week Low | $1.50 |
| Avg Volume (90d) | 1.5M |
Technical Indicators
| SMA 50 | $3.10 |
| SMA 200 | $5.39 |
| 30-day Volatility (annualised) | 119.8% |
| Price vs SMA 50 | -35.1% |
| Price vs SMA 200 | -62.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $23.22 | |
| 2025-11 | $12.72 | -45.2% |
| 2025-12 | $5.82 | -54.2% |
| 2026-01 | $6.66 | +14.4% |
| 2026-02 | $3.24 | -51.4% |
| 2026-03 | $2.16 | -33.3% |
| 2026-04 | $2.83 | +31.0% |
| 2026-05 | $11.88 | +319.8% |
| 2026-06 | $4.99 | -58.0% |
| 2026-07 | $3.20 | -35.9% |
| 2026-08 | $3.59 | +12.2% |
| 2026-09 | $2.01 | -44.0% |
Price
| Price | $2.01 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.08 |
| EV / EBITDA | -1.60 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.88 |
| Current Ratio | 0.06 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -8.57 |